Kwong Lung Enterprise Co., Ltd.(TW:8916)
NT$39.50-0.30 (-0.75%)
TW:8916
Kwong Lung Enterprise Co., Ltd. financials statements
NT$39.50
At close:-0.30 (-0.75%)
Kwong Lung Enterprise Co., Ltd. (8916) Ratios
Kwong Lung Enterprise Co., Ltd. Ratios
TW:8916's free cash flow for Q2 2026 was NT$-301.99M. For the 2026 fiscal year, TW:8916's free cash flow was increased by NT$919.00K and operating cash flow was NT$-302.91M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.18 | 1.47 | 2.33 | 2.15 | 2.14 |
| Quick Ratio | 0.70 | 0.72 | 1.38 | 1.27 | 1.18 |
| Cash Ratio | 0.27 | 0.19 | 0.54 | 0.64 | 0.55 |
| Solvency Ratio | 0.12 | 0.18 | 0.31 | 0.36 | 0.21 |
| Operating Cash Flow Ratio | 0.33 | 0.03 | 0.73 | 0.66 | -0.20 |
| Short-Term Operating Cash Flow Coverage | 0.52 | 0.07 | 2.29 | 1.87 | -0.47 |
| Net Current Asset Value | NT$ -347.32M | NT$ 606.92M | NT$ 1.64B | NT$ 2.17B | NT$ 2.02B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.24 | 0.14 | 0.16 | 0.22 |
| Debt-to-Equity Ratio | 0.56 | 0.42 | 0.19 | 0.24 | 0.37 |
| Debt-to-Capital Ratio | 0.36 | 0.29 | 0.16 | 0.19 | 0.27 |
| Long-Term Debt-to-Capital Ratio | 0.12 | 0.11 | 0.08 | 0.07 | 0.11 |
| Financial Leverage Ratio | 1.82 | 1.76 | 1.42 | 1.54 | 1.67 |
| Debt Service Coverage Ratio | 0.23 | 0.50 | 1.33 | 1.04 | 0.52 |
| Interest Coverage Ratio | 9.41 | 16.21 | 23.57 | 45.49 | 13.49 |
| Debt to Market Cap | 0.39 | 0.27 | 0.12 | 0.18 | 0.32 |
| Interest Debt Per Share | 20.24 | 16.38 | 7.57 | 10.14 | 14.00 |
| Net Debt to EBITDA | 3.21 | 1.91 | 0.17 | -0.18 | 0.67 |
| Profitability Margins | |||||
| Gross Profit Margin | 15.34% | 17.30% | 17.01% | 16.43% | 11.43% |
| EBIT Margin | 5.56% | 10.02% | 10.01% | 9.26% | 6.28% |
| EBITDA Margin | 7.56% | 11.98% | 12.13% | 10.91% | 8.51% |
| Operating Profit Margin | 5.56% | 7.31% | 7.75% | 9.26% | 2.33% |
| Pretax Profit Margin | 5.94% | 9.40% | 9.68% | 10.73% | 6.11% |
| Net Profit Margin | 4.42% | 7.72% | 7.49% | 8.92% | 6.39% |
| Continuous Operations Profit Margin | 4.42% | 7.68% | 7.49% | 8.90% | 6.08% |
| Net Income Per EBT | 74.32% | 82.14% | 77.40% | 83.15% | 104.64% |
| EBT Per EBIT | 106.92% | 128.64% | 124.98% | 115.90% | 262.12% |
| Return on Assets (ROA) | 3.85% | 5.93% | 7.24% | 10.73% | 6.21% |
| Return on Equity (ROE) | 7.01% | 10.45% | 10.32% | 16.50% | 10.39% |
| Return on Capital Employed (ROCE) | 7.46% | 8.32% | 9.55% | 15.47% | 3.24% |
| Return on Invested Capital (ROIC) | 4.12% | 5.51% | 6.77% | 10.91% | 2.04% |
| Return on Tangible Assets | 3.86% | 5.94% | 7.27% | 10.77% | 6.25% |
| Earnings Yield | 5.02% | 7.02% | 6.93% | 13.13% | 9.68% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.35 | 6.99 | 8.93 | 7.90 | 5.71 |
| Payables Turnover | 11.41 | 6.29 | 9.93 | 10.41 | 8.48 |
| Inventory Turnover | 4.41 | 2.61 | 3.91 | 4.07 | 2.98 |
| Fixed Asset Turnover | 5.69 | 3.22 | 4.01 | 5.88 | 4.75 |
| Asset Turnover | 0.87 | 0.77 | 0.97 | 1.20 | 0.97 |
| Working Capital Turnover Ratio | 7.83 | 4.09 | 3.05 | 3.68 | 3.25 |
| Cash Conversion Cycle | 94.41 | 134.24 | 97.48 | 100.92 | 143.35 |
| Days of Sales Outstanding | 43.70 | 52.18 | 40.87 | 46.21 | 63.93 |
| Days of Inventory Outstanding | 82.70 | 140.06 | 93.37 | 89.77 | 122.47 |
| Days of Payables Outstanding | 32.00 | 58.00 | 36.76 | 35.06 | 43.05 |
| Operating Cycle | 126.41 | 192.24 | 134.24 | 135.98 | 186.40 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 7.52 | 0.71 | 8.59 | 11.92 | -3.87 |
| Free Cash Flow Per Share | 6.16 | -1.67 | 6.74 | 9.87 | -6.41 |
| Dividend Paid and CapEx Coverage Ratio | 1.51 | 0.12 | 1.50 | 2.22 | -0.66 |
| Capital Expenditure Coverage Ratio | 5.54 | 0.30 | 4.66 | 5.74 | -1.52 |
| Operating Cash Flow Coverage Ratio | 0.38 | 0.04 | 1.16 | 1.19 | -0.28 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.01 | 0.16 | 0.15 | -0.06 |
| Free Cash Flow Yield | 12.38% | -2.90% | 11.85% | 18.84% | -15.80% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.92 | 14.26 | 14.48 | 8.01 | 11.33 |
| Price-to-Sales (P/S) Ratio | 0.88 | 1.10 | 1.08 | 0.68 | 0.66 |
| Price-to-Book (P/B) Ratio | 1.40 | 1.49 | 1.49 | 1.26 | 1.07 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.08 | -34.48 | 8.44 | 5.31 | -6.33 |
| Price-to-Operating Cash Flow Ratio | 6.62 | 81.57 | 6.62 | 4.40 | -10.48 |
| Price-to-Earnings Growth (PEG) Ratio | -0.52 | 5.09 | -0.36 | 0.10 | 0.20 |
| Enterprise Value Multiple | 14.85 | 11.09 | 9.08 | 6.04 | 8.43 |
| Enterprise Value | 9.58B | 10.48B | 8.49B | 6.79B | 5.78B |
| EV to EBITDA | 14.85 | 11.09 | 9.08 | 6.04 | 8.43 |
| EV to Sales | 1.12 | 1.33 | 1.10 | 0.66 | 0.72 |
| EV to Free Cash Flow | 10.31 | -41.64 | 8.60 | 5.15 | -6.88 |
| EV to Operating Cash Flow | 8.45 | 98.52 | 6.75 | 4.27 | -11.39 |
| Tangible Book Value Per Share | 35.62 | 39.47 | 38.07 | 41.44 | 37.62 |
| Shareholders’ Equity Per Share | 35.66 | 38.69 | 38.24 | 41.68 | 37.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.18 | 0.23 | 0.19 | 0.25 |
| Revenue Per Share | 56.60 | 52.38 | 52.65 | 77.12 | 61.42 |
| Net Income Per Share | 2.50 | 4.04 | 3.95 | 6.88 | 3.93 |
| Tax Burden | 0.74 | 0.82 | 0.77 | 0.83 | 1.05 |
| Interest Burden | 1.07 | 0.94 | 0.97 | 1.16 | 0.97 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
| SG&A to Revenue | 0.09 | 0.09 | 0.09 | 0.07 | 0.08 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.24 | 0.14 | 2.18 | 1.73 | -0.99 |
Currency in TWD
